84 F.4th 713
7th Cir.2023Background
- Fieste was indicted for threatening to assault/kill two federal judges, three former presidents, and the President; arrested Jan. 2022 and has remained in custody.
- Competency evaluations at FMC Carswell found Fieste incompetent due to delusions (diagnoses varied among evaluators: bipolar I with psychotic features, delusional disorder, schizoaffective disorder). Experts agreed medication likely to improve competence.
- Fieste initially improved on injectable antipsychotic (Prolixin) but later refused medication; BOP found she was not dangerous in custody and declined involuntary treatment under Harper.
- Government moved under Sell to involuntarily medicate to restore competency; a hearing followed with expert testimony about prognosis, treatment (long‑acting injectable antipsychotic), and side effects.
- District court granted the Sell motion adopting the government’s proposed order but did not specify a medication dose range; order stayed pending appeal.
- Seventh Circuit affirmed that Sell factors 1 and 2 were met but vacated/remanded because the order lacked a required dosage range and meaningful limits on medical discretion.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| 1. Whether the government established an important interest in prosecution (Sell factor one) | Gov't: Crimes are violent and target public officials; prosecution furthers public security, deterrence, supervised‑release monitoring, and firearms prohibition—so interest is strong despite pretrial confinement. | Fieste: Special circumstances (likely civil commitment; lengthy pretrial detention likely exceeding expected sentence/time served) diminish the government’s interest. | Held: Gov't met burden. Pretrial confinement reduced but did not outweigh the gov't’s strong interests; civil‑commitment argument not sufficiently raised below. |
| 2. Who must present evidence of "special circumstances" that mitigate gov't interest | Gov't: Ultimate burden on gov't to prove important interest, but court can assess facts. | Fieste: Court should consider special circumstances even if not specially developed by defendant. | Held: Defendant must come forward with evidence of special circumstances; gov't still bears ultimate burden to prove important interest by clear and convincing evidence. |
| 3. Whether proposed involuntary treatment is substantially likely to restore competence (Sell factor two) | Gov't: Experts agreed long‑acting injectable antipsychotic (e.g., Prolixin) is substantially likely to restore competence; observed past improvement supports prognosis. | Fieste: District court overrelied on generalized statistics and literature rather than individualized findings; side effects could impair trial ability. | Held: No clear error. Court permissibly credited experts’ combined use of literature, clinical observations, and observed prior response to medication; side‑effect concerns were manageable. |
| 4. Whether the Sell order was sufficiently specific (medication and dose limits) | Gov't: Court may defer dosage decisions to treating clinicians; defense agreed court need not micromanage dosages at hearing. | Fieste: Order lacked required specificity (dose or dose range) and thereby left prison medical staff with unfettered discretion. | Held: Vacated in part and remanded. Court must specify medication(s)/dose range or incorporate a sufficiently detailed treatment plan to constrain medical discretion. |
Key Cases Cited
- Sell v. United States, 539 U.S. 166 (2003) (four‑factor framework allowing involuntary medication to restore competency in rare circumstances)
- Washington v. Harper, 494 U.S. 210 (1990) (permitting involuntary medication of prisoners when dangerousness standard met)
- Riggins v. Nevada, 504 U.S. 127 (1992) (recognizing substantial liberty interest in avoiding forced antipsychotic medication)
- United States v. Breedlove, 756 F.3d 1036 (7th Cir. 2014) (Sell orders must identify medication or range, dose range, and length of treatment)
- United States v. Debenedetto, 757 F.3d 547 (7th Cir. 2014) (government must meet a higher standard under Sell and courts must consider special circumstances)
- United States v. Gutierrez, 704 F.3d 442 (5th Cir. 2013) (discussing assessment of government interest and civil commitment implications)
- United States v. Grigsby, 712 F.3d 964 (6th Cir. 2013) (district court must consider expert testimony about likely civil commitment when assessing Sell factor one)
- United States v. Evans, 404 F.3d 227 (4th Cir. 2005) (threats to federal judges/public officials are serious offenses supporting Sell factor one)
- United States v. White, 620 F.3d 401 (4th Cir. 2010) (measuring pretrial confinement against likely sentence/Guidelines when evaluating Sell factor one)
- United States v. Dillon, 738 F.3d 284 (D.C. Cir. 2013) (Sell analysis and civil‑commitment considerations)
- United States v. Hernandez‑Vasquez, 513 F.3d 908 (9th Cir. 2008) (courts should avoid micromanaging precise medical treatment but must provide judicial safeguards)